Guinea pigs immunized with hepatitis B surface antigen (HBsAg), types adw, adr and ayw, and with two major polypeptides derived from HBsAg/adw developed cell-mediated immunity as determined by the macrophage migration inhibition assay. Peritoneal exudate cells from animals immunized with a 22000-or a 25000-mol. wt. polypeptide derived from HBsAg/adw showed significant migration inhibition after challenge with either polypeptide or with purified HBsAg. Significant inhibition of macrophage migration was not observed when polypeptidesensitized cells were challenged with normal human serum or with normal human liver extract. Similarly, a cell-mediated immune response was not observed in peritoneal exudate cells from animals sensitized to normal human serum or normal human liver extract which were challenged with either of the polypeptides. The humoral immune response to either of the polypeptides, as measured by radioimmunoassay, was substantially lower than that observed in animals immunized with intact particles. This apparent difference between cellular and humoral responses suggests that the macrophage migration assay is a sensitive indicator of the immunogenicity of the smaller mol. wt. HBsAg-derived polypeptides in guinea pigs.
INTRODUCTION
Attempts to propagate hepatitis B virus (HBV) in cultured normal cells as a source of material for vaccine production have been unsuccessful. However, large quantities of HBV-related particles containing hepatitis B surface antigen (HBsAg) can be recovered from the serum of persistently infected individuals. Various reports suggest that normal human serum-like (Millman et al. I97I ; Neurath, Prince & Lippin, I974) and liver-specific, lipoprotein-like (Lee et al. I975; Zuckerman, I975) components may be incorporated within the particles. Consequently, immunization could result in the induction of a hepatitis-like auto-immune response in certain recipients. Utilization of individual HBsAg-derived polypeptides, on the other hand, may be more propitious since these subunits are free of detectable nucleic acid and may be analysed for the presence of host-derived components.
Procedures employed in this laboratory for the isolation of polypeptides from solubilized purified 22 nm HBsAg particles have been reported (Dreesman et aL I975a; Dreesman, G. A. CABRAL AND OTHERS Hollinger & Melnick, I975b) . These preparations elicited humoral and cellular responses in experimental animals (Dreesman et aL I975a; Cabral et aL I975) -Future consideration of polypeptide preparations as vaccine candidates depends on the development of techniques that will yield relatively high concentrations of purified subunits in an aqueous medium.
In this communication, we report on the measurement of cellular and humoral responses in guinea pigs elicited by HBsAg, by highly purified preparations of two major HBsAgderived subunits, and by normal human serum or liver extracts.
METHODS
Purification and isolation ofHBsAg polypeptides. Spherical, 22 -I-2 nm particles containing HBsAg/adw were isolated from human plasma as previously described (Dreesman et al. i972; Hollinger, I974) . Briefly, the particles were pelleted for I8 h at J35ooo g and 4 °C, re-suspended in saline, and re-pelleted for 4 h at t77ooo g and 4 °C. The resulting pellet was re-suspended in 0"05 M-potassium-phthalate-HC1 buffer, pH 2.6, incubated for t h at room temperature and twice banded in caesium chloride (CsC1) at 220000 g and 4 °C for 24 h each. The second isopycnic density centrifugation was followed by a rate-zonal centrifugation at 220000 g and 4 °C for 5 h in a pre-formed 5 to 30 ~o (w/w) CsC1 gradient. CsC1 was removed by extensive dialysis against o.t 5 M-NaC1 and fractions containing HBsAg were identified by a complement-fixation test using guinea pig anti-HBs serum (Hollinger, I974). Protein concentrations of each purified preparation were determined by the Lowry technique (Lowry et al. 195 I) using crystalline bovine serum albumin as a standard. The type specificity of HBsAg in the original plasma stock was established by doublediffusion in agarose using adw and ayw type-specific antisera.
Purified HBsAg particles were solubilized by heating at too °C for 2 min in 0"5 M-urea, I ~oo sodium dodecyl sulphate (SDS) and I ~ 2-mercaptoethanol, and the subunits were then fractionated. Since in our initial studies isolation of individual polypeptides by preparative polyacrylamide gel electrophoresis (PAGE) was relatively inefficient (Dreesman et al. ~975a; Cabral et al. I975) , in the present investigation solubilized HBsAg was fractionated on Io ~ polyacrylamide gels prepared as previously described (Chairez et al. I974) in ~4"5 x I25 mm gel tubes. The proteins were separated using a Bio-Rad model 3oi electrophoresis cell. As much as 2 mg of purified solubilized HBsAg was placed on each cylindrical gel. After electrophoresis at 2o mA/gel tube, a small wedge-shaped section was longitudinally cut from each gel and the remainder was returned to the gel tubes and frozen. The section was stained with o'25 ~ Coomassie brilliant blue and subsequently used to localize each individual protein band by denoting the position of each protein on the stained wedge and extrapolating for its location on the gel. Standards of known mol. wt. were used to estimate the size of each protein (Chairez et al. I974) . The corresponding segments were cut out and each purified polypeptide was recovered from the gel slice by the following procedure. Two ml of o.I ~ SDS were applied to each gel slice. After homogenization, the suspension was frozen and thawed and sonicated for 3 min. The supernatant was collected after centrifugation for 3o min at 25ooo rev/min in a fixed angle Spinco 5o.I rotor. This procedure was repeated twice and the three supernatant solutions were pooled and subsequently concentrated by vacuum dialysis. The concentrate was then dialysed extensively against distilled water. With this technique, approximately 6o to 7o of each protein could be recovered with more than 95 ~ purity, as demonstrated by analytical PAGE in o'75 mm thick slabs of IO ~ acrylamide (Fields et al. r977) .
Immunization of animals. Adult (400 to 500 g) male Hartley guinea pigs were inoculated in the rear and front footpads and in the hind flanks on days o, 14 and 28, respectively. Animals were injected with the 22 ooo-mol, wt. (pz2) and 25 ooo-mol, wt. (p25) polypeptides, with purified type-specific adw, adj" or ayw HBsAg, or with normal human liver extract (NHL) or normal human serum (NHS). The NHL was prepared by freeze-thawing a liver sample three times, followed by homogenization and clarification by low-speed centrifugation at 4 °C. The resultant supernatant was then filtered through a o.45 #m Millipore filter. Both the NHL preparation and the NHS were assayed for the presence of HBsAg by solid-phase radioimmunoassay (Ausria-125I, Abbott Laboratories, North Chicago, Illinois). Cryostat sections of the same liver were also examined using fluoresceinated anti-HBs or anti-HBc (antibody to the hepatitis B core antigen). In no case was there evidence for the presence of either HBsAg or HBcAg. NHS was screened by the Ausria II-125I test for the presence of HBsAg and was subsequently heat-inactivated for 3o min at 56 °C and stored at -7o °C for 98 h. Each animal received a total of 25 #g of antigen in an emulsion consisting of r part saline solution and I part complete Freund's adjuvant per inoculation. Control animals were injected with saline in complete Freund's adjuvant. Guinea pigs were evaluated for the development of cellular and humoral immunity on days 38 to 4o postinoculation.
Cellular immunity assays. Cellular immunity was measured in vitro by the macrophage migration inhibition assay (Lamelin, I97i ; David & David, I972) . Peritoneal exudate cells were harvested from guinea pigs and prepared for in vitro assays using procedures previously described (Cabral et al. I975) .
Cell suspensions were incubated for I h at room temperature with gentle agitation with equal volumes of medium containing 25 #g of polypeptide, intact HBsAg particles, normal human serum, previously heat-inactivated for 30 min at 56 °C and then stored at -70 °C for 98 h, human liver extract prepared by homogenization in saline and subsequently clarified by low-speed centrifugation, or saline (as a control). Cells obtained from selected animals were also incubated with keyhole limpet haemocyanin as controls. Cells were packed in 2o/zl capillary pipettes (Drummond Scientific Co., Broomall, Pennsylvania), placed in duplicate sets of coded sterile Mackaness-type chambers. After 24 and 48 h of incubation at 37 °C, areas of migration were projected on a Nikon Profile Projector mode/ 6C (Nippon Kogaku, Japan), traced on uniform-weight paper and weighed. The percentage inhibition of migration was determined using the following formula:
•mean wt. of migration\ Using this formula, an inhibition of 2o ~ or greater was selected as indicative of development of cellular immunity. Assay for antibody. Antibody titres to HBsAg were determined by radioimmunoassay using the staphylococcal protein A assay to separate bound 125i_HBsAg/anti_HB s complexes from the free 125I-HBsAg fraction as previously described (Figenschau & Ulstrup, 1974; . Precipitating antibody to HBsAg was measured by micro agar gel diffusion (Hollinger, 1974)-Antibody reactivity to NHS protein components was analysed by immunoelectrophoresis (Scheidegger, 1955) 
RESULTS

Purity of HBsAg and HBsAg-derived polypeptide preparations
The starting preparation appeared as a monodispersed solution of spheres having a mean diam. of 22___ 2 nm (Fig. i) . This preparation contained 3oo to 5o0/~g/ml of protein and approx. 5 × Io13 particles/ml. Guinea pigs were immunized with three inoculations of purified HBsAg-associated particles emulsified in Freund's complete adjuvant. All produced pre- cipitating anti-HBs with titres ranging from I : 8 to I : 64 when tested by agar gel diffusion. However, several of these sera contained antibody which reacted with NHS proteins, as determined by immunoelectrophoresis. Specific precipitin lines were formed with human IgG, a-and fl-globulins and albumin (Fig. 2) . This observation is similar to that reported previously by this laboratory (Dreesman et al. ~972) as well as by others (Millman et al. I97I ; Neurath et al. I974) . Two mg of the above purified particles were solubilized and fractionated on Io polyacrylamide gels. A representative stained wedge of such a gel is shown in Fig. 3 . Polypeptides with mol. wt. of 22ooo and 25ooo (p22 and p25, respectively) were cut out as indicated on Fig. 3 and subsequently eluted and dialysed. These preparations showed no detectable traces of any other proteins (Fig. 4a, b) and contained Ioo to I5o #g ofprotein/ml.
Cellular immunity
Cellular immunity in guinea pigs was measured by the macrophage migration inhibition assay. Table I summarizes the results of those guinea pigs which were immunized (1) with purified 2o_+ 2 nm particles containing type-specific adw, adr or ayw HBsAg, (2) with p22 or p25 derived from HBsAg/adw, or (3) with complete Freund's adjuvant.
Peritoneal exudate (PE) cells obtained from five guinea pigs inoculated with p22 and challenged with the same antigen exhibited a 52 to 84 ~ decrease in macrophage migration. Similarly, significant inhibition of macrophage migration above 2o ~ was observed when the same PE cells were challenged with the p25 preparation. Inhibition, ranging from 40 to 8I ~, was observed when the cells were challenged with purified, whole particle HBsAg, regardless of the subtype.
Mononuclear cells obtained from animals immunized with p25 were inhibited from 24 to 87 ~o when challenged with this polypeptide. Evidence of cellular immunity to the paz subunit and to the various whole particle preparations was also noted. Similarly, guinea pigs injected with mixtures of p22 and p25 or with the purified HBsAg whole particle preparations exhibited evidence for the development of cellular immunity when their PE cells were challenged with the homologous or heterologous antigen or with either of the two polypeptide preparations. Minimal inhibition (< 20 ~) occurred among exudate cells of adjuvant-inoculated animals challenged with polypeptides or with whole particles. In addition, cells obtained from selected animals previously inoculated with either of the polypeptides or with intact HBsAg particles did not demonstrate significant migration inhibition when challenged with keyhole limpet haemocyanin (data not shown).
G. A. C A B R A L A N D O T H E R S
Additional guinea pigs were immunized with NHS, with NHL extract, or with p22 or p25. The results are summarized in Table 2 . Cell migration was markedly inhibited in animals inoculated and subsequently challenged with the homologous antigen preparation. On the other hand, macrophage inhibition greater than 20 ~ was not demonstrated by cells of guinea pigs inoculated with NHS or with NHL and then challenged with the p22 or p25 subunits. Nor was inhibition of migration noted among PE cells of animals injected with either of the polypeptides and then challenged with NHS or NHL.
Humoral immunity
Humoral immunity was evaluated in all guinea pigs by radioimmunoassay. The results are summarized in Table 3 . Reciprocal antibody titres of animals inoculated with purified whole particles, as established by the staphylococcal protein A procedure using a25I-labelled intact HBsAg/adw, ranged from 29ooo to 9ooooo. Significantly lower titres were noted for animals inoculated with the polypeptide preparations. However, no antibody to NHS components was detected in those animals immunized with p22 and p25 when these antisera were analysed by immunoelectrophoresis. No anti-HBs was detected in sera of animals injected with NHS, NHL or adjuvant.
DISCUSSION
Viral hepatitis type B presents a serious health risk to certain individuals, particularly health care personnel, haemodialysis patients and staff, infants born to mothers with the disease, spouses of acute hepatitis cases, persons receiving blood transfusions, and drug abusers. Thus, the need for a suitable vaccine is evident. However, the use of whole particle vaccines must be considered with caution since reports indicate that host-derived com- • NHS screened by Ausria II-1~5I test for absence of HBsAg and heat-inactivated for 3o rain at 56 °C then stored at -7o °C for 98 h to remove cytotoxic factors.
t ND = not done. :~ No inhibition when compared to unchallenged PE cells. In some cases, migration was enhanced.
ponents may be associated with these particles (Millman et al. t97t; Neurath et al. I974; Lee et al. 1975; Zuckerman, I975 (Chairez et al. I973, ~975) , the subunit may differ from p22 only in containing this moiety. Of particular interest was the ability of PE cells from animals inoculated with the HBsAg/adw-derived polypeptides to respond to challenge with intact surface particles of the three subtypes. Mononuclear cells from animals sensitized with the polypeptides were not inhibited from migrating when challenged with normal human serum or normal human liver extract. Furthermore, inhibition (i.e., above our cut-off point of 2o ~) was not observed among PE cells from animals injected with these human constituents and challenged with the polypeptide preparations. These observations suggest, therefore, that host-derived material is not associated with the p22 or p25 polypeptides. These results are of particular interest since inoculation of individuals with HBsAg components associated with host-derived or host-specific substances could result in the induction of a hepatitis-like auto-immune response.
The relatively low anti-HBS response observed in the serum of potypeptide-inoculated guinea pigs is difficult to assess. It has been shown that immunogenic activity varies among the different mol. wt. polypeptides. In fact, some HBsAg-derived polypeptides did not induce anti-HBs antibodies (Dreesman et aL I975a) . On the other hand, some authors have reported that all of the HBsAg polypeptides were not only capable of inducing anti-HBs in guinea pigs but also induced subtype-or group-specific antibodies (Gold et al., 1976 ) . It is noteworthy that in the present investigation antibody titres in sera of animals inoculated with HBsAg spherical particles or with HBsAg-derived polypeptides were determined by radioimmunoassay using intact 125I-labelled HBsAg/adw. Furthermore, it has been demonstrated that antibodies formed to conformationalty intact proteins (e.g., bovine pancreatic ribonuclease, lysozyme) cross-react poorly with the same protein following denaturation. Conversely, antibodies formed to denatured, random-coil protein forms cross-react poorly with native proteins (Brown, 1962; Brown et aL 1959, I963; Gerwing & Thompson, 1968; Young & Leung, 197o; Thompson et al. 1972) . Consequently, the use of whole 12.Si_labelled particles to measure antibody titres in sera of guinea pigs inoculated with either of the polypeptide preparations may have been inappropriate. On the other hand, it has been suggested that antigenic recognition in cellular immune processes is less dependent on conformation than are humoral antibodies (Parish, I97I; Thompson et al. 1972) . The in vitro evidence for cellular immunity to HBsAg elicited by the two polypeptides therefore suggests that these components may prove useful for vaccine application, particularly since there is increasing evidence that cell-mediated immune responses play a major role in host defences against various virus infections (Allison, 1967; Glasgow, [97o; Tompkins et al. I97oa, b) . In addition, the results of this investigation indicate that crossreaction with normal human components does not occur with either the p22 or the p25 polypeptides. Therefore, inclusion of both in a single preparation should be considered, thus allowing for a greater yield of HBsAg-specific protein for a potential vaccine.
